These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 28910618)

  • 1. RAN Translation Regulated by Muscleblind Proteins in Myotonic Dystrophy Type 2.
    Zu T; Cleary JD; Liu Y; Bañez-Coronel M; Bubenik JL; Ayhan F; Ashizawa T; Xia G; Clark HB; Yachnis AT; Swanson MS; Ranum LPW
    Neuron; 2017 Sep; 95(6):1292-1305.e5. PubMed ID: 28910618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alternative initiation factor eIF2A plays key role in RAN translation of myotonic dystrophy type 2 CCUG•CAGG repeats.
    Tusi SK; Nguyen L; Thangaraju K; Li J; Cleary JD; Zu T; Ranum LPW
    Hum Mol Genet; 2021 May; 30(11):1020-1029. PubMed ID: 33856033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
    Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
    Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of the rate of protein translation in patients with myotonic dystrophy 2.
    Huichalaf C; Schoser B; Schneider-Gold C; Jin B; Sarkar P; Timchenko L
    J Neurosci; 2009 Jul; 29(28):9042-9. PubMed ID: 19605641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCUG repeats reduce the rate of global protein synthesis in myotonic dystrophy type 2.
    Schneider-Gold C; Timchenko LT
    Rev Neurosci; 2010; 21(1):19-28. PubMed ID: 20458885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy.
    Sznajder ŁJ; Swanson MS
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31323950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecules that target the toxic RNA in myotonic dystrophy type 2.
    Nguyen L; Lee J; Wong CH; Zimmerman SC
    ChemMedChem; 2014 Nov; 9(11):2455-62. PubMed ID: 24938413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms.
    Meola G; Cardani R
    Biochim Biophys Acta; 2015 Apr; 1852(4):594-606. PubMed ID: 24882752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy Brain.
    Goodwin M; Mohan A; Batra R; Lee KY; Charizanis K; Fernández Gómez FJ; Eddarkaoui S; Sergeant N; Buée L; Kimura T; Clark HB; Dalton J; Takamura K; Weyn-Vanhentenryck SM; Zhang C; Reid T; Ranum LP; Day JW; Swanson MS
    Cell Rep; 2015 Aug; 12(7):1159-68. PubMed ID: 26257173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound loss of muscleblind-like function in myotonic dystrophy.
    Lee KY; Li M; Manchanda M; Batra R; Charizanis K; Mohan A; Warren SA; Chamberlain CM; Finn D; Hong H; Ashraf H; Kasahara H; Ranum LP; Swanson MS
    EMBO Mol Med; 2013 Dec; 5(12):1887-900. PubMed ID: 24293317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
    Michel L; Huguet-Lachon A; Gourdon G
    PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Toxic RNA Catalyzes the Cellular Synthesis of Its Own Inhibitor, Shunting It to Endogenous Decay Pathways.
    Benhamou RI; Angelbello AJ; Wang ET; Disney MD
    Cell Chem Biol; 2020 Feb; 27(2):223-231.e4. PubMed ID: 31981476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing.
    Dhaenens CM; Tran H; Frandemiche ML; Carpentier C; Schraen-Maschke S; Sistiaga A; Goicoechea M; Eddarkaoui S; Van Brussels E; Obriot H; Labudeck A; Gevaert MH; Fernandez-Gomez F; Charlet-Berguerand N; Deramecourt V; Maurage CA; Buée L; Lopez de Munain A; Sablonnière B; Caillet-Boudin ML; Sergeant N
    Biochim Biophys Acta; 2011 Jul; 1812(7):732-42. PubMed ID: 21439371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
    Lin X; Miller JW; Mankodi A; Kanadia RN; Yuan Y; Moxley RT; Swanson MS; Thornton CA
    Hum Mol Genet; 2006 Jul; 15(13):2087-97. PubMed ID: 16717059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocytochemical study.
    Perdoni F; Malatesta M; Cardani R; Giagnacovo M; Mancinelli E; Meola G; Pellicciari C
    Eur J Histochem; 2009 Sep; 53(3):e18. PubMed ID: 19864209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2.
    Mankodi A; Urbinati CR; Yuan QP; Moxley RT; Sansone V; Krym M; Henderson D; Schalling M; Swanson MS; Thornton CA
    Hum Mol Genet; 2001 Sep; 10(19):2165-70. PubMed ID: 11590133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear localization of MBNL1: splicing-mediated autoregulation and repression of repeat-derived aberrant proteins.
    Kino Y; Washizu C; Kurosawa M; Oma Y; Hattori N; Ishiura S; Nukina N
    Hum Mol Genet; 2015 Feb; 24(3):740-56. PubMed ID: 25274774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myotonic Dystrophy: an RNA Toxic Gain of Function Tauopathy?
    Fernandez-Gomez F; Tran H; Dhaenens CM; Caillet-Boudin ML; Schraen-Maschke S; Blum D; Sablonnière B; Buée-Scherrer V; Buee L; Sergeant N
    Adv Exp Med Biol; 2019; 1184():207-216. PubMed ID: 32096040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.